Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

Share Price is delayed by 15 minutes
Get Live Data
5.75    -0.10 (-1.71%)
Bid:
5.70
Ask:
5.80
Spread: 0.10 (1.754%)
Market Cap: £61.50m
STX Live PriceLast checked at - London Stock Exchange

Intraday Shield Thera Share Chart

Shield Thera News

TRADING UPDATES: Corcel buys Wo Wo Gap project; Amiad, UDG leave LSE
12 Aug 2021

TRADING UPDATES: Corcel buys Wo Wo Gap project; Amiad, UDG leave LSE

TRADING UPDATES: Corcel buys Wo Wo Gap project; Amiad, UDG leave LSE

Shield Therapeutics inks exclusive licence for 'Accrufer' in Korea
12 Aug 2021

Shield Therapeutics inks exclusive licence for 'Accrufer' in Korea

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics has entered into an exclusive licence agreement for 'Accrufer', it anno...

TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million
9 Aug 2021

TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million

TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million

TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook
24 Jun 2021

TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook

TRADING UPDATES: Vitec and Allergy Therapeutics lift full-year outlook

EXECUTIVE CHANGES: Trident Royalties picks ex-Glencore member as chair
18 Jun 2021

EXECUTIVE CHANGES: Trident Royalties picks ex-Glencore member as chair

EXECUTIVE CHANGES: Trident Royalties picks ex-Glencore member as chair

UK shareholder meetings calendar - next 7 days
10 Jun 2021

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

EXECUTIVE CHANGES: Mitchells & Butlers slims board following fundraise
28 May 2021

EXECUTIVE CHANGES: Mitchells & Butlers slims board following fundraise

EXECUTIVE CHANGES: Mitchells & Butlers slims board following fundraise

Shield Therapeutics appoints industry veteran Greg Madison as CEO
28 May 2021

Shield Therapeutics appoints industry veteran Greg Madison as CEO

(Sharecast News) - Commercial stage pharmaceutical company Shield Therapeutics announced on Friday that Greg Madison has been appointed as its chief e...